Down 50%: Broker tips A2 Milk (ASX:A2M) and this ASX share to rebound in 2022

Every dog has its day…

| More on:
asx share price rise represented by rebounding bar chart

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This year is on course to be a highly successful one for Australian investors. Barring an end of year pullback, the S&P/ASX 200 Index (ASX: XJO) is currently on track to record a gain of over 12% in 2021.

Unfortunately, not all shares have been able to follow the market higher this year. The two ASX shares listed below, for example, have lost over 50% of their value since the start of the year.

While this is very disappointing, the team at Bell Potter is tipping a big rebound in 2022. Here's why they could be buys:

A2 Milk Company Ltd (ASX: A2M)

The A2 Milk share price is down a disappointing 52% in 2021. This has been caused by a significant reduction in sales and profits due to structural changes in the Chinese infant formula market which management failed to anticipate.

Bell Potter believes that a turnaround is coming and doesn't believe this is being reflected in its shares. As a result, the broker has named the company among its top picks for 2022 with a buy rating and $7.70 price target.

The broker commented: "We see the scope for EPS to double by FY26e, if A2M can execute on the China offline expansion strategy, while recovering 50% of the lost sales (from FY20-21) in English label IMF. The catalyst to regaining lost English label sales is likely to be border reopening and the return of international students. Exiting the loss making US assets or navigating a turnaround at the MVM asset would likely accelerate this turnaround. We do not see the current share price as reflecting this potential."

Doctor Care Anywhere Group PLC (ASX: DOC)

The Doctor Care Anywhere share price has been sold off and is down by a whopping 56% year to date to 54.5 cents. This means the telehealth's company's shares are now trading 32% lower than their IPO listing price of 80 cents from December of last year.

Bell Potter appears to see this as a buying opportunity for investors. The broker has put a buy rating and lofty $1.30 price target on its shares. This suggests that its shares could more than double in 2022.

Its analysts explained: "DOC experienced exceptional growth during the first 9 months of calendar year 2021 with appointment volumes growing from an average of 30,000 per month in 1Q21 to nearly 40,000 per month by 3Q21. Due to unprecedented demand growth, the company supplemented its supply of doctors with short term contractors which resulted in a decline in margins. DOC has now increased capacity for 45,000 consultations per month from September 2021 and we expect a bounce in margins for the final quarter with ongoing margin growth in CY22."

Should you invest $1,000 in Coronado Global Resources Inc. right now?

Before you buy Coronado Global Resources Inc. shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Coronado Global Resources Inc. wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended A2 Milk and Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cheap Shares

Two workers on site discuss the next stage of this civil engineering job, one points his hands upwards.
Cheap Shares

2 ASX 200 shares this fund manager thinks are trading at great value

These large industry players are good value.

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Cheap Shares

2 ASX 200 shares with favourable risk-reward profiles

I think these two blue chips are worth a look right now.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

3 cheap ASX 200 shares with big dividends to consider buying right now

These businesses offer impressive levels of passive income.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Cheap Shares

3 beaten-down ASX 200 shares to consider buying before the next bull market

These shares could be cheap according to analysts. Here's why now they could be a buy.

Read more »

Some kids fly a kite in strong winds at sunset.
Cheap Shares

Childcare in focus this Federal Election: how much upside does Macquarie expect for G8 Education shares?

Here’s why a broker is bullish about this stock.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

I think these 2 cheap ASX shares are buys for value investors

I like the price and potential of these businesses.

Read more »

Cheap Shares

3 oversold ASX shares begging to rebound

Analysts think these shares are too cheap to ignore at current levels.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Cheap Shares

Down 20% to 40%: These oversold ASX shares could be bargains hiding in plain sight

These shares could be bargain buys according to analysts.

Read more »